Koninklijke Philips NV 2024 AR2
The report highlights Royal Philips' solid progress in the second year of its 2023-2025 operating plan, delivering EUR 18.0 billion in sales with a 1% comparable sales growth. The company achieved significant milestones in resolving the Respironics recall litigation in the US and signed a consent decree. In sustainability, Philips improved the lives of 1.96 billion people, including 242 million in underserved communities, and increased its circular revenues to 24% of sales. Additionally, the company maintained carbon neutrality in its operations and achieved 100% EcoDesigned new product introductions.
Company: Koninklijke Philips NV
Sector: Health Care
Country: Netherlands
Year: 2024
Type: AR2
Pages: 302
Koninklijke Philips NV
Annual Report
The report highlights Royal Philips' solid progress in the second year of its 2023-2025 operating plan, delivering EUR 18.0 billion in sales with a 1% comparable sales growth. The company achieved significant milestones in resolving the Respironics recall litigation in the US and signed a consent decree. In sustainability, Philips improved the lives of 1.96 billion people, including 242 million in underserved communities, and increased its circular revenues to 24% of sales. Additionally, the company maintained carbon neutrality in its operations and achieved 100% EcoDesigned new product introductions.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2024
Reporting Period
Jan 1, 2024 - Dec 31, 2024
Fiscal Year
2024
Published
Feb 21, 2025
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Reporting Standards
Materiality Assessment
Assurance
Assurance Provider
Assurance Standard
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Emissions
Scope 1:
Scope 2:
Scope 3:
Energy Consumption
Renewable Energy
Water Consumption
Total Waste
Women on Board
Women in Management
Workplace Fatalities
Employees